Subscribe To

Price Alert Latest News Economic Calendar News

NEO / Why NeoGenomics Stock Is Plunging Today

NeoGenomics Inc's (NASDAQ: NEO) CEO Mark Mallon will step down as CEO and member of the Board, effective immediately. The Board has retained Russell Reynolds to search for the Company's next CEO The Board has appointed current Chair Lynn Tetrault, Esq. Read More

Demo Live Account See Partner Details

Content Topics

Neogenomics

Stock

Plunging

Today

NEO

Posted: Mar 29 2022, 09:54

Author Name: Benzinga

NEO News

By Zacks Investment Research
October 24, 2023

Bull of the Day: NeoGenomics (NEO)

NeoGenomics ( NEO ) is a small-cap provider of cancer genetics diagnostics. They boast one of the most comprehensive oncology-focused testing menus in

By Accesswire
October 17, 2023

NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023

FT. MYERS, FL / ACCESSWIRE / October 17, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research se

By Zacks Investment Research
October 13, 2023

NeoGenomics (NEO) Upgraded to Strong Buy: What Does It Mean for the Stock?

NeoGenomics (NEO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might dr

By Seeking Alpha
August 8, 2023

NeoGenomics, Inc (NEO) Q2 2023 Earnings Call Transcript

NeoGenomics, Inc (NASDAQ:NEO ) Q2 2023 Earnings Conference Call August 8, 2023 8:30 AM ET Company Participants Kendra Sweeney - Vice President, Invest

By Zacks Investment Research
August 8, 2023

NeoGenomics (NEO) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for NeoGenomics (NEO) give a sense of how its business performed in the quarter ended June 2023, it might be worth consid

By Seeking Alpha
May 18, 2023

NeoGenomics: What Lies Ahead

Today, we take our first look at NeoGenomics, Inc., a company focused on oncology testing. NeoGenomics has strung together a series of strong quarterl

By Seeking Alpha
May 8, 2023

NeoGenomics, Inc. (NEO) Q1 2023 Earnings Call Transcript

NeoGenomics, Inc. (NASDAQ:NEO ) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Kendra Sweeney - VP of IR Chris Smith - C

By Seeking Alpha
February 23, 2023

NeoGenomics, Inc. (NEO) Q4 2022 Earnings Call Transcript

NeoGenomics, Inc. (NASDAQ:NEO ) Q4 2022 Earnings Conference Call February 23, 2023 8:30 AM ET Company Participants Chris Smith - Chief Executive Offic

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.